OncLive® On Air

Hodgkin's Lymphoma

Chemotherapy

Oncology

Colorectal Cancer

Nivolumab

Onc201

Hepatic Artery Infusion

H3K27M Mutant Diffuse Midline Gliomas

Immunotherapy

CAR T-Cell Therapy

ACTION Trial

Her2-Positive Breast Cancer

Ponatinib

FDA Approval

Swog 1826

Siltocaptagine Autolucel

Multiple Myeloma

Colorectal Cancer Management

Malignant Perivascular Epithelioid Cell Tumors

Glioma

In OncLive® On Air, you can expect to hear interviews with academic oncologists on the thought-provoking oncology presentations they give at the OncLive® State of the Science Summits. The topics in oncology vary, from systemic therapies, surgery, radiation therapy, to emerging therapeutic approaches in a particular type of cancer. This includes lung cancer, breast cancer, gastrointestinal cancers,... more

31 ratings

Publishes	Daily	Episodes	500	Founded	8 years ago
Number of Listeners		Categories	Health & FitnessScience

Listen to this Podcast

Guests Host Reviews Charts Talking Points

Latest Episodes

S16 Ep53: Live Tumor Board: Squamous Cell Carcinoma of the Head & Neck - Post-CRT Decisions in the Locally Advanced Setting

In this podcast, experts Barbara Burtness, MD; and Quynh-Thu Le, MD, FACR, FASTRO; discuss recent and ongoing trials and key updates in the management of locally advanced head and neck cancer.

17 Apr 2026 • 32 min

S16 Ep52: Medical Crossfire®: PD-L1 Inhibition in Advanced Cutaneous Squamous Cell Carcinoma — Mechanistic Rationale and Clinical Application

In this podcast, experts April K.S. Salama, MD; Omid Hamid, MD; James M.G. Larkin, MD, PhD; and Sapna Patel, MD; discuss the data for immune checkpoint inhibitors used to treat advanced cutaneous squamous cell carcinoma, including a review of PD-1 ve... more

15 Apr 2026 • 31 min

S16 Ep51: Medical Crossfire®: Translating Risk Into Action—Redefining Adjuvant Strategies for Early HR+/HER2– Breast Cancer

In this podcast, experts Ann H. Partridge, MD, MPH; Saranya Chumsri, MD; and William J. Gradishar, MD, FASCO, FACP, discuss the roles of adjuvant chemotherapy and CDK4/6 inhibitors and neoadjuvant checkpoint inhibitors for patients with early-stage, ... more

14 Apr 2026 • 28 min

S16 Ep49: Medical Crossfire®: Redefining Frontline and Maintenance Strategies in HER2+ Metastatic Breast Cancer

In this podcast, experts Joyce O’Shaughnessy, MD; Reshma L. Mahtani, DO; Heather McArthur, MD, MPH; and Paolo Tarantino, MD, PhD; discuss results of recent frontline maintenance trials for patients with HER2-positive (HER2+) metastatic breast cancer ... more

10 Apr 2026 • 19 min

Key Facts

Accepts Guests

Contact Information

Podcast Host

Number of Listeners

Find out how many people listen to this podcast per episode and each month.

Similar Podcasts

People also subscribe to these shows.

Two Onc DocsSam and Karine

Oncology Brothers: Practice-Changing Cancer DiscussionsOncology Brothers

Oncology Today with Dr Neil LoveDr. Neil Love

Research To Practice | Oncology VideosDr Neil Love

ASCO Daily NewsAmerican Society of Clinical Oncology (ASCO)

Recent Guests

Joyce O'Shaughnessy

Oncologist mentioned as part of the panel

Episode: S16 Ep49: Medical Crossfire®: Redefining Frontline and Maintenance Strategies in HER2+ Metastatic Breast Cancer

Charles M. Rudin

Leading oncologist discussed in episode intro

Episode: S16 Ep48: Shifting the Paradigm in Small Cell Lung Cancer: Targeting Tumor Biology to Transform Patient Outcomes

Mazyar Shadman

MD, MPH; Professor in the Clinical Research Division, Medical Director of Cellular Immunotherapy, Innovators Network Endowed Chair

Fred Hutchinson Cancer Center

Episode: S16 Ep47: The Intricacies of Approved Therapies Pose Questions for CLL Management: With Mazyar Shadman, MD, MPH

David Morris

MD, FACS

Episode: S16 Ep43: FDA Approval Insights: Rucaparib for BRCA Mutation–Associated mCRPC: With David Morris, MD, FACS; and Alan H. Bryce, MD

Alan H. Bryce

Episode: S16 Ep43: FDA Approval Insights: Rucaparib for BRCA Mutation–Associated mCRPC: With David Morris, MD, FACS; and Alan H. Bryce, MD

Katharine Esselen

Attending gynecologic oncologist; Assistant professor of obstetrics, gynecology, and reproductive medicine

Beth Israel Deaconess Medical Center; Harvard Medical School

Episode: S16 Ep41: The Price of Survival: Addressing Financial Toxicity in Gynecologic Oncology With Ursula A. Matulonis, MD; and Katharine M. Esselen, MD, MBA

Miguel Perales

Medical professional discussed in the episode

Episode: S16 Ep37: Show Me the Data®: How Today’s Evidence Is Shaping Tomorrow’s Management and Prophylaxis of Chronic GVHD

Curie L. Kitko

Medical professional discussed in the episode

Episode: S16 Ep37: Show Me the Data®: How Today’s Evidence Is Shaping Tomorrow’s Management and Prophylaxis of Chronic GVHD

Amandeep Salhotra

Medical professional discussed in the episode

Episode: S16 Ep37: Show Me the Data®: How Today’s Evidence Is Shaping Tomorrow’s Management and Prophylaxis of Chronic GVHD

Host

Courtney Flaherty

Host of OncLive On Air

Reviews

4.5 out of 5 stars from 31 ratings

Best option for CME podcasts
Love the content! Easily the best platform for listening to CME and staying updated while on the go. Keep up the great work!
Apple Podcasts
5
Dlshaka
United States10 months ago
My favorite podcast for oncology
This podcast provides excellent information to anyone who works in the medical field on oncology.
Apple Podcasts
5
Chiliman1986
United States6 years ago

Embed These Reviews on a Website

Listeners Say

Key themes from listener reviews, highlighting what works and what could be improved about the show.

The show is highly regarded for its focused content on oncology, which is seen as valuable for those in the medical field.

Listeners appreciate the wealth of information provided, particularly highlighting its relevance for continuing medical education and professional growth.

Chart Rankings

How this podcast ranks in the Apple Podcasts, Spotify and YouTube charts.

Apple Podcasts

#197

Japan/Health & Fitness

Talking Points

Recent interactions between the hosts and their guests.

S16 Ep47: The Intricacies of Approved Therapies Pose Questions for CLL Management: With Mazyar Shadman, MD, MPH

Q: Moving forward, what additional research would you like to see to help refine these treatment decisions in CLL?

I hope for more collaborative analyses across multiple trials and access to patient-level data to enable deeper, multi-angle evaluations; faster, more efficient trials with practical endpoints would help us refine decision-making and optimize patient outcomes.

S16 Ep47: The Intricacies of Approved Therapies Pose Questions for CLL Management: With Mazyar Shadman, MD, MPH

Q: Regarding safety, what were the key takeaways from this analysis?

Safety was evaluated with continuous Xanibrutinib versus fixed-duration Calbrutinib plus Venetoclax, showing similar or higher rates of certain adverse events with continuous therapy, including higher serious treatment-emergent adverse events, underscoring the need to balance efficacy with toxicity.

S16 Ep47: The Intricacies of Approved Therapies Pose Questions for CLL Management: With Mazyar Shadman, MD, MPH

Q: What were the notable design features of this indirect comparison? How is the indirect comparison conducted?

We used two complementary approaches: first, selecting a Sequoia sub-population that mirrored Amplify's healthier baseline characteristics using factors like serous score and renal function, and excluding patients with P53 mutations; second, applying MIAC to compare adjusted Sequoia data with Amplify, ensuring more robust cross-trial alignment.

S16 Ep47: The Intricacies of Approved Therapies Pose Questions for CLL Management: With Mazyar Shadman, MD, MPH

Q: What efficacy data from the indirect comparison did you find most striking or significant?

The analysis suggested that, over similar follow-up durations, Xanibrutinib showed numerically higher three-year progression-free survival than Calbrutinib plus Venetoclax, and this difference became more pronounced when adjusting populations for comparable eligibility, reinforcing the potential advantage of continuous BTK inhibition in terms of PFS.

S16 Ep42: Variability and Innovation in Small Cell Lung Cancer Care: With Ticiana Leal, MD

Q: What practical barriers prevent community patients from enrolling in trials and what models have you seen that bridge that gap?

Barriers include lack of information offered to patients, logistical hurdles, and limited access to trials in community settings. Solutions involve proactively offering trials, decentralizing trials to community sites, providing transportation and navigator support, and building real-world trial designs that are inclusive of diverse patient populations.

Audience Metrics

Listeners, social reach, demographics and more for this podcast.

Listeners per Episode
Gender Skew
Location
Interests
Professions
Age Range
Household Income
Social Media Reach

Frequently Asked Questions About OncLive® On Air

What is OncLive® On Air about and what kind of topics does it cover?

Focusing on the latest advancements in oncology, this show offers insights from academic oncologists on cutting-edge research and treatments. Discussions range across various cancer types, including lung, breast, gastrointestinal, hematologic, gynecologic, and genitourinary cancers, reflecting a comprehensive approach to modern cancer care. Unique to this program is its emphasis on both systemic therapies and innovative therapeutic methods, providing listeners with a deep understanding of emerging trends in oncology.

Where can I find podcast stats for OncLive® On Air?

Rephonic provides a wide range of podcast stats for OncLive® On Air. We scanned the web and collated all of the information that we could find in our comprehensive podcast database. See how many people listen to OncLive® On Air and access YouTube viewership numbers, download stats, audience demographics, chart rankings, ratings, reviews and more.

How many listeners does OncLive® On Air get?

Rephonic provides a full set of podcast information for three million podcasts, including the number of listeners. View further listenership figures for OncLive® On Air, including podcast download numbers and subscriber numbers, so you can make better decisions about which podcasts to sponsor or be a guest on. You will need to upgrade your account to access this premium data.

What are the audience demographics for OncLive® On Air?

Rephonic provides comprehensive predictive audience data for OncLive® On Air, including gender skew, age, country, political leaning, income, professions, education level, and interests. You can access these listener demographics by upgrading your account.

How many subscribers and views does OncLive® On Air have?

To see how many followers or subscribers OncLive® On Air has on Spotify and other platforms such as Castbox and Podcast Addict, simply upgrade your account. You'll also find viewership figures for their YouTube channel if they have one.

Which podcasts are similar to OncLive® On Air?

These podcasts share a similar audience with OncLive® On Air:

1. Two Onc Docs
2. Oncology Brothers: Practice-Changing Cancer Discussions
3. Oncology Today with Dr Neil Love
4. Research To Practice | Oncology Videos
5. ASCO Daily News

How many episodes of OncLive® On Air are there?

OncLive® On Air launched 8 years ago and published 500 episodes to date. You can find more information about this podcast including rankings, audience demographics and engagement in our podcast database.

How do I contact OncLive® On Air?

Our systems regularly scour the web to find email addresses and social media links for this podcast. We scanned the web and collated all of the contact information that we could find in our podcast database. But in the unlikely event that you can't find what you're looking for, our concierge service lets you request our research team to source better contacts for you.

Where can I see ratings and reviews for OncLive® On Air?

Rephonic pulls ratings and reviews for OncLive® On Air from multiple sources, including Spotify, Apple Podcasts, Castbox, and Podcast Addict.

View all the reviews in one place instead of visiting each platform individually and use this information to decide if a show is worth pitching or not.

How do I access podcast episode transcripts for OncLive® On Air?

Rephonic provides full transcripts for episodes of OncLive® On Air. Search within each transcript for your keywords, whether they be topics, brands or people, and figure out if it's worth pitching as a guest or sponsor. You can even set-up alerts to get notified when your keywords are mentioned.

What guests have appeared on OncLive® On Air?

Recent guests on OncLive® On Air include:

1. Joyce O'Shaughnessy
2. Charles M. Rudin
3. Mazyar Shadman
4. David Morris
5. Alan H. Bryce
6. Katharine Esselen
7. Miguel Perales
8. Curie L. Kitko

To view more recent guests and their details, simply upgrade your Rephonic account. You'll also get access to a typical guest profile to help you decide if the show is worth pitching.

Find and pitch the right podcasts

We help savvy brands, marketers and PR professionals to find the right podcasts for any topic or niche. Get the data and contacts you need to pitch podcasts at scale and turn listeners into customers.

Try it free for 7 days